Diseases with indications for total hip arthroplasty
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 ~ 80 years old, regardless of gender; 2.Patients who meet the requirements of total hip arthroplasty and need the primary total hip arthroplasty according to the evaluation of the researchers; 3.The subjects fully understand the benefits and risks of this trial and are willing to participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with neuromuscular dysfunction (e.g. paralysis, myolysis or abductor weakness) that can lead to postoperative hip instability or abnormal gait; 2.Active infection lesions in the hip joint or other parts of the body; 3.Patients with severe hip deformity and hip dysplasia with Crowe grade 3 or 4; 4. Ankylosing spondylitis patients with bony ankylosis or severe stiffness; 5. Patients with bilateral hip arthroplasty at the same time, or patients with contralateral hip arthroplasty within 3 months, or patients with contralateral hip arthroplasty expected to be performed within 1 year after operation; 6. The patient known to have a history of allergy to one or more implanted materials; 7. Patients with severe internal and surgical diseases or weak physique and unable to tolerate surgery; 8. Patients with poor expected compliance; 9. Pregnant or lactating women, or patients with family planning during clinical research; 10.The patient participating in other drug clinical trials within 3 months before enrollment, or other device clinical trials within 1 month before enrollment; 11. Other circumstances that the researchers consider inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRP (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation); | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);IL-6 (within 7 days before operation, 6h after operation, 1 day after operation, 3 days after operation and 21 days after operation);Cortisol (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation and 21 days after operation);Lactate dehydrogenase (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);Creatine kinase (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation and 21 days after operation);Alkaline phosphatase (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);Serum amyloid A (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation and 21 days after operation);Leukocyte count (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);Percentage of lymphocytes (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation) ;Percentage of monocytes (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);HCT (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);Hemoglobin (within 7 days before operation, 6 hours after operation, 1 day after operation, 3 days after operation, 21 days after operation);Active hip flexion angle (within 7 days before operation, 3 days after operation and 21 days after operation);Active hip abduction angle (within 7 days before operation, 3 days after operation and 21 days after operation) ;Standing and walking test (within | — |
Countries
China
Contacts
West China Hospital of Sichuan University